摘要
在自然界中,致病性寄生虫的驱虫药物的敏感性不同图案比比皆是。在这个意义上,从植物中提取的天然产品是一种具有潜在的抗寄生虫活性的药物的效力。不幸的是,有许多代谢物和研究都将付出昂贵的金钱和资源。为此,理论研究,如QSAR模型可能是有用的。这些,在大多数情况下,预测的生物活性的药物对一个单一的寄生虫物种。因此,预测的概率与一种药物是有效对抗许多不同的物种与一个单一的QSAR模型是一种重要的成就。本文共分三个部分:第一部分是综述中代谢产物的性质,抗寄生虫活性,尤其是抗原生动物(Leishmania和锥虫);第二部分包括审查理论研究寻找一个模型,预测天然产物的杀虫活性;第三部分和最后一部分涉及的理论模型研究药物与受体之间的相互作用,具有杀虫活性的新的代谢产物分析。
关键词: 抗原生动物,药物受体、代谢产物、天然产物、定量构效关系。
图形摘要
Current Drug Targets
Title:Review of Theoretical Models to Study Natural Products with Antiprotozoal Activity
Volume: 18 Issue: 5
关键词: 抗原生动物,药物受体、代谢产物、天然产物、定量构效关系。
摘要: In nature, pathogenic parasite species with different susceptibility patterns of antiparasitic drugs abound. In this sense, natural products derived from plants are a potency for drugs with potential antiparasitic activity. Unfortunately, there are many metabolites and studying all of them would be costly in terms of money and resources. To this end, theoretical studies such as QSAR models could be useful. These, for the most part, predict the biological activity of the drugs against a single species of parasite. Consequently, foretell the probability with which a drug is active against many different species with a single QSAR model is an important achievement. This review consists of three parts: the first part is a review of metabolites found in nature that have antiparasitic activity, in particular the antiprotozoal (Leishmania and Trypanosoma); the second part includes a review of theoretical studies looking for a model that predicts the antiprotozoal activity of natural products; the third and final part concerns the study of theoretical models focused on the interaction between drug and receptor, analyzing new metabolites with antiprotozoal activity.
Export Options
About this article
Cite this article as:
Review of Theoretical Models to Study Natural Products with Antiprotozoal Activity, Current Drug Targets 2017; 18 (5) . https://dx.doi.org/10.2174/1389450117666161222161335
DOI https://dx.doi.org/10.2174/1389450117666161222161335 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glucocorticoid Regulates Parkin Expression in Mouse Frontal Cortex: Implications in Schizophrenia
Current Neuropharmacology New Therapeutic Strategies for Coeliac Disease: Tissue Transglutaminase as a Target
Current Medicinal Chemistry The Role of Cytokine Network in the Pathophysiology of Schizophrenia
Current Psychiatry Reviews Allosteric Inhibition of G-Protein Coupled Receptor Oligomerization: Strategies and Challenges for Drug Development
Current Topics in Medicinal Chemistry Safety and Complications Reporting Update on the Re-Implantation of Culture-Expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique
Current Stem Cell Research & Therapy Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy The Novel Multi-Target Iron Chelator, M30 Modulates HIF-1α-Related Glycolytic Genes and Insulin Signaling Pathway in the Frontal Cortex of APP/PS1 Alzheimer’s Disease Mice
Current Alzheimer Research Current Treatment Concepts of Philadelphia-Negative MPN
Current Cancer Drug Targets Neuroimaging Correlates of 22q11.2 Deletion Syndrome: Implications for Schizophrenia Research
Current Topics in Medicinal Chemistry Melatonin: Pharmacology, Functions and Therapeutic Benefits
Current Neuropharmacology Neutralizing Endogenous VEGF Following Traumatic Spinal Cord Injury Modulates Microvascular Plasticity but not Tissue Sparing or Functional Recovery
Current Neurovascular Research Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology
Current Topics in Medicinal Chemistry Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Current Neuropharmacology The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe
Current Drug Metabolism Hypersensitivity to Lamotrigine and Nonaromatic Anticonvulsant Drugs: A Review
Current Pharmaceutical Design The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers
Current Drug Targets General Anesthetics in Brain Injury: Friends or Foes?
Current Pharmaceutical Design Intrahippocampal Transplantation of Undifferentiated Human Chorionic- Derived Mesenchymal Stem Cells Does Not Improve Learning and Memory in the Rat Model of Sporadic Alzheimer Disease
Current Stem Cell Research & Therapy